Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microsaic Systems Wins R&D 100 Award for the World’s Most Compact Mass Spectrometer

Published: Friday, June 22, 2012
Last Updated: Friday, June 22, 2012
Bookmark and Share
Microsaic’s 3500 MiD mass spectrometer has been chosen winner by an independent judging panel and the editors of R&D Magazine.

Microsaic Systems plc has announced that its 3500 MiD mass spectrometer has been chosen as an R&D 100 award winner by an independent judging panel and the editors of R&D Magazine.

The award recognizes the 3500 MiD as one of the most technologically significant products to enter the marketplace in 2011.

Microsaic is the first and only company to have commercialized MS (mass spectrometry) technology on a chip. The instrument distinguished itself among other entries as the chips allow production of MS detectors that are smaller, lighter, consume less energy, are easier to maintain and cheaper to run than conventional MS systems.

MS is widely accepted as one of the most reliable methods for identifying chemicals, and MS systems are used to accurately identify the chemicals that make up gaseous, liquid and solid samples.

MS is used across a range of sectors including government, energy, utilities, pharmaceuticals, environmental, food & drink, healthcare and industrial chemicals.

Although fast and sensitive, typical MS systems are large, heavy, energy intensive, expensive and complex to use, as a result, MS systems tend to be shared, central facilities.

The 3500 MiD represents a step change in the ease of use and footprint of mass spectrometry.

Most revolutionary is the fact that the 3500 MiD, uniquely, is fully self contained, making it highly portable. All other commercial mass spectrometers have external vacuum pumps, which typically sit on the floor and connect to the instrument with vacuum hoses.

The 3500 MiD’s small size - about one third that of the main unit of typical competitors - means it can be easily incorporated within a stack or cluster of instruments on a particular chemist’s work space - it is even small enough to sit inside a fume hood.

This results in greater workplace productivity, by giving chemists access to immediate results, offering economic benefit in areas such as drug discovery and synthesis.

It will also bring the accuracy and reliability of mass spectrometry to on-site analysis applications such as sports forensics, food & beverage quality, and oil and gas exploration.

“The awards have long been a benchmark of excellence so we are delighted to have been selected for the R&D 100 award - the competition has been strong this year so it is a great achievement to be acknowledged by industry leaders as one of the most valuable and significant products released to the market,” said Professor Eric Yeatman, CEO of Microsaic Systems.

Professor Yeatman continued, “The 3500 MiD is the culmination of over a decade of research, bringing together two high tech fields - chemical analysis and silicon micro-engineering - to make possible a transformative capability in detection. Its low operating cost and small footprint make the 3500 MiD deployable in a wide range of applications where mass spectrometry has not been able to reach until now - a true innovation.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Microsaic Systems Signs Commercial Agreement
Second major agreement for novel miniaturized chip-based scientific instrument.
Thursday, April 11, 2013
Microsaic Systems Appoints Colin Jump as New CEO
Company to drive the commercialization of its revolutionary chip-based technology.
Tuesday, November 06, 2012
Microsaic Systems Appoint Sales and Marketing Manager
Microsaic Systems plc announces that Samantha Dunnage has joined to lead the Company’s marketing and direct sales.
Monday, August 08, 2011
Scientific News
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
Hunting the Missing Link Between Genetics and the Environment
The International Phenome Centre Network (IPCN) works to transform healthcare through phenomics - the dynamic interactions between our genes and our environment.
Cocaine Test Could Lead to Rapid, Low Cost Roadside Testing
Scientists develop urine and oral fluid diagnostic test for cocaine, utilising a compact mass spectrometer.
The Benefits of a Mediterranean-style Diet
A Western-style diet, with more omega-6 fatty acids than the Mediterranean, dysregulates lipid signaling in aged mice and promotes inflammation.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Rapid Identification of Illicit Designer Drugs
New technique can identify commonly used illicit compounds in as little as 15 seconds.
Enhancing On-line Biological Sample Processing
New techniques are required to meet emerging demands on biopharmaceutical analysis.
Early Warning System for Colorectal Cancer
Potential new diagnostic tool identified for the second most common cancer in the world.
Scientists Develop a Novel Method to Benchmark and Improve the Performance of Protein Measurement Techniques
A wide range of laboratories around the world are benefiting from this work, which enables researchers to analyze or compare the results of quantitative proteomics assays in a standardized way.
Amyloid Study Pinpoints Protein Culprits
A five-year trial at a Brisbane Hospital has increased the accuracy of diagnosing patients with amyloidosis, a group of rare and incurable diseases caused by abnormal protein deposits in tissues and organs.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!